Acme United [ACU] vs Park Ha Biological [PHH] Detailed Stock Comparison
Acme United
NYSE
Loading...
Park Ha Biological
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Acme United wins in 12 metrics, Park Ha Biological wins in 3 metrics, with 0 ties. Acme United appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Acme United | Park Ha Biological | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.87 | 26.34 | Acme United |
| Price-to-Book Ratio | 1.44 | 3.48 | Acme United |
| Debt-to-Equity Ratio | 30.04 | 2.15 | Park Ha Biological |
| PEG Ratio | 4.08 | N/A | N/A |
| EV/EBITDA | 9.62 | -0.71 | Park Ha Biological |
| Profit Margin (TTM) | 5.33% | 91.80% | Park Ha Biological |
| Operating Margin (TTM) | 11.83% | -1,591.00% | Acme United |
| EBITDA Margin (TTM) | 11.83% | N/A | N/A |
| Return on Equity | 9.50% | -729.77% | Acme United |
| Return on Assets (TTM) | 5.09% | -298.12% | Acme United |
| Free Cash Flow (TTM) | $4.83M | $874,901 | Acme United |
| Dividend Yield | 1.55% | N/A | N/A |
| 1-Year Return | -1.51% | -88.21% | Acme United |
| Price-to-Sales Ratio (TTM) | 0.84 | 5.36 | Acme United |
| Enterprise Value | $193.96M | $13.44M | Acme United |
| EV/Revenue Ratio | 1.00 | 4.85 | Acme United |
| Gross Profit Margin (TTM) | 41.02% | N/A | N/A |
| Revenue per Share (TTM) | $52 | $0 | Acme United |
| Earnings per Share (Diluted) | $2.55 | $-0.72 | Acme United |
| Beta (Stock Volatility) | 0.69 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Acme United vs Park Ha Biological Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Acme United | 4.91% | 3.24% | 2.82% | 7.16% | 13.24% | 15.52% |
| Park Ha Biological | -7.66% | -14.29% | -41.46% | -96.50% | -91.75% | -89.57% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Acme United | -1.51% | 50.66% | 83.73% | 150.89% | 338.86% | 182.33% |
| Park Ha Biological | -88.21% | -88.21% | -88.21% | -88.21% | -88.21% | -88.21% |
Performance & Financial Health Analysis: Acme United vs Park Ha Biological
| Metric | ACU | PHH |
|---|---|---|
| Market Information | ||
| Market Cap | $163.44M | $153.50M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 7,630 | 945,390 |
| 90 Day Avg. Volume | 8,747 | 830,203 |
| Last Close | $44.43 | $0.45 |
| 52 Week Range | $34.35 - $45.42 | $0.43 - $41.49 |
| % from 52W High | -2.18% | -98.93% |
| All-Time High | $50.99 (Jan 22, 2024) | $41.34 (Jul 08, 2025) |
| % from All-Time High | -12.87% | -98.91% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.03% | 0.45% |
| Quarterly Earnings Growth | 0.07% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.92% |
| Operating Margin (TTM) | 0.12% | -15.91% |
| Return on Equity (TTM) | 0.10% | -7.30% |
| Debt to Equity (MRQ) | 30.04 | 2.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $29.93 | $0.15 |
| Cash per Share (MRQ) | $0.96 | $0.05 |
| Operating Cash Flow (TTM) | $18.24M | $1.17M |
| Levered Free Cash Flow (TTM) | $10.03M | $5.11M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.55% | N/A |
| Last 12-Month Dividend | $0.60 | N/A |
Valuation & Enterprise Metrics Analysis: Acme United vs Park Ha Biological
| Metric | ACU | PHH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.87 | 26.34 |
| Forward P/E | 19.21 | N/A |
| PEG Ratio | 4.08 | N/A |
| Price to Sales (TTM) | 0.84 | 5.36 |
| Price to Book (MRQ) | 1.44 | 3.48 |
| Market Capitalization | ||
| Market Capitalization | $163.44M | $153.50M |
| Enterprise Value | $193.96M | $13.44M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.00 | 4.85 |
| Enterprise to EBITDA | 9.62 | -0.71 |
| Risk & Other Metrics | ||
| Beta | 0.69 | N/A |
| Book Value per Share (MRQ) | $29.93 | $0.15 |
Financial Statements Comparison: Acme United vs Park Ha Biological
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ACU | PHH |
|---|---|---|
| Revenue/Sales | $45.96M | N/A |
| Cost of Goods Sold | $28.04M | N/A |
| Gross Profit | $17.92M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $2.43M | N/A |
| EBITDA | $4.05M | N/A |
| Pre-Tax Income | $2.12M | N/A |
| Income Tax | $466,000 | N/A |
| Net Income (Profit) | $1.65M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ACU | PHH |
|---|---|---|
| Cash & Equivalents | $3.45M | $547,498 |
| Total Current Assets | $96.85M | $2.84M |
| Total Current Liabilities | $20.07M | $1.52M |
| Long-Term Debt | $33.21M | $52,745 |
| Total Shareholders Equity | $108.28M | $1.51M |
| Retained Earnings | $95.59M | $271,788 |
| Property, Plant & Equipment | $4.44M | $70,739 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ACU | PHH |
|---|---|---|
| Operating Cash Flow | $-1.63M | N/A |
| Capital Expenditures | $-1.35M | N/A |
| Free Cash Flow | $-4.69M | N/A |
| Debt Repayment | $-99,000 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ACU | PHH |
|---|---|---|
| Shares Short | 89,654 | 1.02M |
| Short Ratio | 9.35 | 1.01 |
| Short % of Float | 0.03% | 0.14% |
| Average Daily Volume (10 Day) | 7,630 | 945,390 |
| Average Daily Volume (90 Day) | 8,747 | 830,203 |
| Shares Outstanding | 3.75M | 26.20M |
| Float Shares | 2.96M | 7.82M |
| % Held by Insiders | 0.12% | 0.73% |
| % Held by Institutions | 0.85% | 0.00% |
Dividend Analysis & Yield Comparison: Acme United vs Park Ha Biological
| Metric | ACU | PHH |
|---|---|---|
| Last 12-Month Dividend | $0.60 | N/A |
| Last 12-Month Dividend Yield | 1.55% | N/A |
| 3-Year Avg Annual Dividend | $0.53 | N/A |
| 3-Year Avg Dividend Yield | 0.46% | N/A |
| 3-Year Total Dividends | $1.60 | N/A |
| Ex-Dividend Date | Mar 26, 2025 | N/A |